(RPTX) Repare Therapeutics - Performance -57.4% in 12m
RPTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-91.84%
#190 in Peer-Group
Rel. Strength
7.69%
#6856 in Stock-Universe
Total Return 12m
-57.36%
#141 in Peer-Group
Total Return 5y
-95.23%
#146 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.99 USD |
| 52 Week Low | 0.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 64.97 |
| Buy/Sell Signal +-5 | 1.45 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RPTX (-57.4%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RPTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RPTX
| Total Return (including Dividends) | RPTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.65% | 2.27% | 4.52% |
| 3 Months | 39.22% | 6.30% | 10.43% |
| 12 Months | -57.36% | -10.68% | 14.67% |
| 5 Years | -95.23% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | RPTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -57.8% | 5.5% | 79.1% |
| 3 Months | 80.3% | 74.3% | 94.2% |
| 12 Months | -69.9% | -84.7% | 44.4% |
| 5 Years | -94.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th65.00 | 1.35% | -0.83% |
| 3 Month | %th82.00 | 30.96% | 26.07% |
| 12 Month | %th30.00 | -52.26% | -62.81% |
| 5 Years | %th27.00 | -93.54% | -97.72% |
FAQs
Does Repare Therapeutics (RPTX) outperform the market?
No,
over the last 12 months RPTX made -57.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months RPTX made 39.22%, while XBI made 6.30%.
Performance Comparison RPTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RPTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.8% | -0.9% | 1.3% | -72% |
| US NASDAQ 100 | QQQ | -1.3% | -1% | 0.1% | -72% |
| German DAX 40 | DAX | -0.1% | 4.7% | -10.2% | -86% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.8% | -0.5% | 0.4% | -75% |
| Hongkong Hang Seng | HSI | -0.1% | -2.4% | -16.5% | -93% |
| India NIFTY 50 | INDA | -1.9% | 1.3% | 3% | -57% |
| Brasil Bovespa | EWZ | -2.9% | -3.9% | -21.6% | -70% |
RPTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.4% | -2.4% | -3.8% | -85% |
| Consumer Discretionary | XLY | -1.2% | 1.6% | 8.5% | -78% |
| Consumer Staples | XLP | -0.8% | 4.1% | 1.7% | -68% |
| Energy | XLE | -0.7% | -0.7% | 7.4% | -54% |
| Financial | XLF | -2.1% | 0% | -2.4% | -87% |
| Health Care | XLV | -2.2% | 0.2% | 7.4% | -53% |
| Industrial | XLI | -2% | -0.4% | -5.8% | -82% |
| Materials | XLB | -2.8% | -0.6% | -1.8% | -63% |
| Real Estate | XLRE | 1.3% | 3% | 2.5% | -71% |
| Technology | XLK | -1.5% | -4.3% | -1% | -68% |
| Utilities | XLU | -0.4% | 3.3% | -1.4% | -82% |
| Aerospace & Defense | XAR | -2.5% | -3.6% | -17.1% | -106% |
| Biotech | XBI | 0.9% | 1.4% | 16.8% | -47% |
| Homebuilder | XHB | -4.4% | -6.8% | 7.9% | -62% |
| Retail | XRT | -2.8% | -0.8% | 7% | -67% |
RPTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.3% | -2.65% | 11.5% | -48% |
| Natural Gas | UNG | 7% | 14.1% | 18.8% | -49% |
| Gold | GLD | -0.4% | 5% | -17.7% | -100% |
| Silver | SLV | -0.4% | 0% | -14% | -79% |
| Copper | CPER | -2.9% | -0.3% | -17.1% | -72% |
RPTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.9% | 0.2% | 5.1% | -59% |
| iShares High Yield Corp. Bond | HYG | 0% | 2.4% | 3.4% | -68% |